Opinion
In-depth effectiveness and safety of nintedanib in treating
idiopathic pulmonary fibrosis: An Indian single-center
observational study
Author(s): Vivek Gupta*
Numerous clinical trials have proven nintedanib's efficacy and safety in the treatment of Idiopathic Pulmonary Fibrosis (IPF). The purpose of this study is to evaluate nintedanib's effectiveness and safety in Indian patients with IPF... Read More»
DOI:
10.37532/pulclr.2022.3(4).27-8
+447723598358